|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash and cash equivalents: | |||||||||||||||||||
| Cash and due from banks | |||||||||||||||||||
| Federal funds sold | |||||||||||||||||||
| Total cash and cash equivalents | |||||||||||||||||||
| Investment securities | |||||||||||||||||||
| Available for sale | |||||||||||||||||||
| Federal Home Loan Bank Stock, at cost | |||||||||||||||||||
| Loans held for sale | |||||||||||||||||||
| Loans, net of allowance of $4,421 and $4,794 | |||||||||||||||||||
| Premises and equipment, net | |||||||||||||||||||
| Other real estate owned, net | |||||||||||||||||||
| Company owned life insurance | |||||||||||||||||||
| Deferred tax asset, net of valuation allowance | |||||||||||||||||||
| Deferred tax asset, net | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Deposits | |||||||||||||||||||
| Noninterest-bearing | |||||||||||||||||||
| Interest-bearing | |||||||||||||||||||
| Total deposits | |||||||||||||||||||
| Federal funds purchased | |||||||||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||||
| Federal Home Loan Bank Borrowings | |||||||||||||||||||
| Junior subordinated debentures | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Shareholders’ Equity | |||||||||||||||||||
| Common stock (no par value; 20,000,000 shares authorized;7,103,751 shares issued and outstanding) | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Total shareholders’ equity | |||||||||||||||||||
| Total liabilities and shareholders’ equity | |||||||||||||||||||
Loading...
